Evidence map›Paper›PMID 33021310›Full record

ReviewBioscience reports2020

The interplay of phenotype and genotype in Cryptococcus neoformans disease.

Sophie Altamirano, Katrina M Jackson, Kirsten Nielsen

Abstract readReview
In one paragraph

Review in Bioscience reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 32 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
32citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

32 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Molecular types, clinical profile, and exploratory virulence-associated phenotypes of clinical Cryptococcus isolates from Amazonas, Brazil.Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology] · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Insights from Mass Spectrometry-Based Proteomics onJournal of fungi (Basel, Switzerland) · 2025
    Review
  9. Article
  10. Transposon load and RNAi loss synergize to drive intraspecies diversity inProceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  11. Article
  12. Mechanisms and Virulence Factors ofJournal of fungi (Basel, Switzerland) · 2024
    Review
  13. The Zanthoxylum armatum fruit's oil exterminates Candida cells by inhibiting ergosterol biosynthesis without generating reactive oxygen species.International microbiology : the official journal of the Spanish Society for Microbiology · 2024
    Article
  14. Article
  15. Antifungal Resistance in Cryptococcal Infections.Pathogens (Basel, Switzerland) · 2024
    Review
  16. Article
  17. Article
  18. Article
  19. Importance of Clinical Isolates inJournal of fungi (Basel, Switzerland) · 2023
    Review
  20. Adaptive immunology ofFrontiers in immunology · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Sophie Altamirano *Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, U.S.A.
Katrina M Jackson *Department of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, U.S.A.
Kirsten NielsenDepartment of Microbiology and Immunology, University of Minnesota, Minneapolis, MN, U.S.A.

Funding

Training Research Educators in Minnesota (TREM) whilst increasing diversityK12GM119955 · NIGMS · UNIVERSITY OF MINNESOTA · PI David Irwin Greenstein, Julia Willett · 2017 to 2026
$6.5M
Impact of Cryptococcus Titan Cells on Pathogenesis.R01AI134636 · NIAID · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Kirsten Nielsen · 2018 to 2026
$4.6M
Genomic Research Capacity Building for Cryptococcosis Translational StudiesR01NS118538 · NINDS · VIRGINIA POLYTECHNIC INST AND ST UNIV · PI Joel Bazira, David Bisagaya Meya · 2020 to 2026
$3.4M
HLA Alleles and the Progression of Human CryptococcosisR21AI150303 · NIAID · UNIVERSITY OF MINNESOTA · PI NIELSEN, KIRSTEN · 2020 to 2021
$438k
Genomic Research Capacity Building for Cryptococcosis Translational StudiesR21NS108715 · NINDS · UNIVERSITY OF MINNESOTA · PI BAZIRA, JOEL, NIELSEN, KIRSTEN · 2018 to 2019
$352k
Single nucleotide variations account for strain specific virulence changes in Cryptococcus neoformansF31AI148047 · NIAID · UNIVERSITY OF MINNESOTA · PI JACKSON, KATRINA M · 2019 to 2021
$95k
NIAID NIH HHS F31 AI148047NIAID NIH HHS R01 AI134636NIAID NIH HHS R21 AI150303NIGMS NIH HHS K12 GM119955NINDS NIH HHS R01 NS118538NINDS NIH HHS R21 NS108715
6 · The paper itself

Abstract

Cryptococcus neoformans is an opportunistic fungal pathogen that causes life-threatening meningitis primarily in immunocompromised individuals. In order to survive and proliferate during infection, C. neoformans must adapt to a variety of stresses it encounters within the host. Patient outcome depends on the interaction between the pathogen and the host. Understanding the mechanisms that C. neoformans uses to facilitate adaptation to the host and promote pathogenesis is necessary to better predict disease severity and establish proper treatment. Several virulence phenotypes have been characterized in C. neoformans, but the field still lacks a complete understanding of how genotype and phenotype contribute to clinical outcome. Furthermore, while it is known that C. neoformans genotype impacts patient outcome, the mechanisms remain unknown. This lack of understanding may be due to the genetic heterogeneity of C. neoformans and the extensive phenotypic variation observed between and within isolates during infection. In this review, we summarize the current understanding of how the various genotypes and phenotypes observed in C. neoformans correlate with human disease progression in the context of patient outcome and recurrence. We also postulate the mechanisms underlying the genetic and phenotypic changes that occur in vivo to promote rapid adaptation in the host.

Indexed as

CryptococcosisCryptococcus neoformansDisease ProgressionEvolution, MolecularGenotypeHost-Pathogen InteractionsHumansPhenotypePrognosisVirulenceVirulence FactorsVirulence FactorsCryptococcus neoformansgenotypemicroevolutionphenotype

Identifiers

PMID33021310
PMCPMC7569153

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.